|
|
| Drug Discovery US 2025: Innovation Takes the Stage in San Diego | Get ready, San Diego! Drug Discovery US 2025 lands this October 2nd - 3rd, bringing world-leading experts in drug product development and delivery to the West Coast’s scientific hub. Dive into presentations, panels, and roundtables—including a featured session on degraders and molecular glues, with case studies on cutting-edge discovery platforms. Cap off the day at our Innovations & Breakthroughs Under the Stars Garden Party. |
|
|
|
|
By AR Welch, Editorial & Community Director, Advancing RNA | In the following Q&A, Ethris CMO Thomas Langenickel shares some of his biggest questions and observations about the evolving mRNA therapeutics space that are the most impactful in translating early-stage RNA candidates into the clinic — particularly when that drug product boasts a novel formulation. | |
|
|
|
Navigating antigen selection for personalized mRNA cancer immunotherapies is a major challenge for industry and regulators. In this clip, CureVac’s Ulrike Jägle articulates why the integration of AI/ML into clinical development presents a significant and ongoing regulatory hurdle. |
|
|
|
|
|
|
|
|
|
| Key Stages In mRNA-Based Therapeutic Development | White Paper | Cytiva | Learn how planning a product development strategy early on with a technology partner who has deep expertise and technical knowledge of genomic medicines can address uncertainties from the outset. |
|
|
|
|
|
| Join the PDA Universe of Pre-Filled Syringes and Injection Devices Conference 2025, taking place 21–22 October in Vienna, Austria! Centered on the theme Shaping the Drug Delivery Ecosystem, this event explores innovation at the intersection of science, technology, sustainability, and patient experience. Expect powerful keynotes, real-world case studies, expert sessions, and a dynamic exhibition showcasing the future of injectable combination products. Make sure to register! |
|
|
|
|
|
|
|
|
|
|
|
| As additional mRNA therapeutics makers progress toward and into the clinic, we're gathering more knowledge about what makes our mRNA products "tick," and how our processes impact the overall quality of our products. Join this expert panel for a timely discussion in the mRNA therapeutics space. Registration is free thanks to the support of Millipore Sigma. |
|
|
.png){kind=logo}
